IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL5.64▼ 0.47% USD/MXN18.58▲ 0.36% USD/CLP996.41▲ 0.15% USD/COP 3,303 — 0.00% USD/PEN3.41▲ 0.11% USD/ARS1,544▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES911.74▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69— 0.00% USD/TTD6.75— 0.00% EUR/BRL6.22▼ 0.53% BRENT 95.55 ▼ 0.30% WTI 88.45 ▼ 0.12% IRON ORE 161.91 — — COPPER 6.04 ▼ 0.73% GOLD 3,875 ▼ 0.30% SILVER 47.63 ▼ 2.87% SOY 1,229 ▼ 1.11% CORN 445.00 ▼ 0.11% WHEAT 589.25 ▼ 0.67% COFFEE 276.60 ▼ 0.74% SUGAR 18.29 ▼ 0.65% ORANGE JUICE 136.85 ▼ 2.91% COTTON 81.51 ▲ 3.47% COCOA 5,302 ▲ 3.57% BEEF 220.65 ▲ 0.80% CATTLE 339.03 ▲ 1.00% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00% IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL 5.64 ▼ 0.47% USD/MXN 18.58 ▲ 0.36% USD/CLP 996.51 ▲ 0.16% USD/COP 3,303 — 0.00% USD/PEN 3.41 ▲ 0.15% USD/ARS 1,544 ▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES 911.74 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.75% USD/TTD 6.75 ▲ 2.58% EUR/BRL 6.22 ▼ 0.53% BRENT 95.55 ▼ 0.30% WTI 88.45 ▼ 0.12% IRON ORE 161.91 — — COPPER 6.04 ▼ 0.73% GOLD 3,875 ▼ 0.30% SILVER 47.63 ▼ 2.87% SOY 1,229 ▼ 1.11% CORN 445.00 ▼ 0.11% WHEAT 589.25 ▼ 0.67% COFFEE 276.60 ▼ 0.74% SUGAR 18.29 ▼ 0.65% ORANGE JUICE 136.85 ▼ 2.91% COTTON 81.51 ▲ 3.47% COCOA 5,302 ▲ 3.57% BEEF 220.65 ▲ 0.80% CATTLE 339.03 ▲ 1.00% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00%
since 2009
Monday, November 16, 2026

Covid-19 Brazil

Brazil’s ANVISA suspends analysis of Indian vaccine Covaxin for lack of essential documents

By · · 2 min read

RIO DE JANEIRO, BRAZIL – Brazil’s National Health Regulatory Agency (ANVISA) extended on Wednesday, June 30, the deadline to complete its analysis of the application for emergency use of the Indian vaccine against Covid-19 Covaxin, because of the absence of mandatory and documents essential for the evaluation of the efficacy and safety of the vaccine, the regulator said.

The vaccine is at the center of the Covid CPI investigation in the Brazilian Senate for alleged irregularities during negotiations.

Brazil’s ANVISA suspends analysis of Indian vaccine Covaxin for lack of essential documents
The application to use the vaccine was filed amid investigations by the Covid-19 CPI into alleged irregularities related to deals with the federal government to purchase Covaxin
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

ANVISA said in an official statement that it had notified Precisa Medicamentos, the author of the application, to provide the outstanding information urgently.

The agency cited several missing documents, including a report on preclinical safety and immunogenicity studies and various efficacy and safety data.

The application to use the vaccine was filed Tuesday, June 29, amid investigations by the Senate Covid CPI and other oversight bodies into alleged irregularities related to deals with the federal government to purchase Covaxin.

These suspicions brought President Jair Bolsonaro to the center of the debate in the Covid CPI. According to testimony by Congressman LuÌs Miranda (DEM-DF) and his brother, Health Ministry official LuÌs Ricardo Miranda, he had been made aware of the alleged irregularities before the CPI last week.

The Ministry of Health has decided to suspend the contract for the purchase of the Indian vaccine. The decision came after a recommendation from the Comptroller General of the Union (CGU), which proposed the suspension of the contract.

The action is precautionary and temporary “for further analysis by the agency,” the Ministry said in a statement. The agreement had been signed In February this year, for the purchase of 20 million doses of the immunizing agent manufactured by the laboratory Bharat Biotech.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.